| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/23/2003 | CN1115098C Method for direct guiding external source DNA into soybean for improving soybean variety |
| 07/22/2003 | USRE38202 Antibodies specific for a haemostatic protein, their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 07/22/2003 | US6597450 Automated Optical Reader for Nucleic Acid Assays |
| 07/22/2003 | US6596930 Modification of cereal grain hardness via expression of puroindoline protein |
| 07/22/2003 | US6596929 Regulatory sequences for use in generation of disease and damage resistant plants |
| 07/22/2003 | US6596928 Plants synthesizing a modified starch, the generation of the plants, their use, and the modified starch |
| 07/22/2003 | US6596927 Genes coding for flavone synthases |
| 07/22/2003 | US6596925 Compositions and methods for the modification of gene expression |
| 07/22/2003 | US6596923 Methods and compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 07/22/2003 | US6596857 Preparation of phosphorothioate oligomers |
| 07/22/2003 | US6596856 Nucleic acid labeling compounds |
| 07/22/2003 | US6596855 Polynucleotide encoding CZF-1 protein |
| 07/22/2003 | US6596854 Human translation protein; for use in the treatment of cancer |
| 07/22/2003 | US6596853 Nucleotide sequences coding polypeptide for use in the treatment of cancer and prevention of infections |
| 07/22/2003 | US6596852 Antibodies that bind the cytokine designated LERK-5 |
| 07/22/2003 | US6596851 Antibody for use in the treatment of cell proliferative disorders |
| 07/22/2003 | US6596850 Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same |
| 07/22/2003 | US6596847 Tissue factor protein variants |
| 07/22/2003 | US6596698 Localized arterial transduction of RB2/pl30 via a viral vector at the time of angioplasty drastically reduces neointimal hyperplasia and prevents restenosis |
| 07/22/2003 | US6596691 Administering therapeutically effective amount of bactericidal/permeability-increasing protein product to a human suffering from meningococcemia |
| 07/22/2003 | US6596541 Genetically engineering preferential immunoglobulins in cells; obtain cells, transform with vector containing genetically engineered immunoglobulin, recover transformed cells, propagate, recover immunoglobulin |
| 07/22/2003 | US6596540 Method for introduction of an exogenous genetic substance or a physiologically active compound |
| 07/22/2003 | US6596539 Modification of virus tropism and host range by viral genome shuffling |
| 07/22/2003 | US6596538 Expression vector coding enzymatic polypeptide for use in the preparation of cosmetics, detergents, plastics and lubricants |
| 07/22/2003 | US6596537 Oligonucleotide for use in the treatment of cancer, infections and autoimmune diseases |
| 07/22/2003 | US6596535 Adeno-associated viral vector for use as tool in the transfer of genetic information for use in the treatment of arthritis |
| 07/22/2003 | US6596534 Utilization of osteocalcin promoter to deliver therapeutic genes to tumors |
| 07/22/2003 | US6596533 Polypeptide for use in the treatment of infections and cell proliferative disorders |
| 07/22/2003 | US6596529 Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof |
| 07/22/2003 | US6596528 Heat-stable D-aminoacylase |
| 07/22/2003 | US6596527 Nucleotide sequences coding enzymatic polypeptide for use in the diagnosis and treatment of liver disorders |
| 07/22/2003 | US6596526 Furin polypeptides with improved characteristics |
| 07/22/2003 | US6596525 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| 07/22/2003 | US6596524 Method for cloning and expression of BsmAi restriction endonuclease and BsmAI methylase in E. coli |
| 07/22/2003 | US6596523 Sialyltransferase for use in the diagnosis and treatment of inflammation and cancer |
| 07/22/2003 | US6596517 Culturing a microorganism having L-glutamic acid- producing ability at a first pH that is suitable for growth of the microorganism, and then culturing the microorganism at a second pH that is suitable for L-glutamic acid production |
| 07/22/2003 | US6596516 Process for the fermentative preparation of L-amino acids using coryneform bacteria |
| 07/22/2003 | US6596515 Insulin gene amplified from human genomic DNA by use of a pair of insulin primers and a K14 promoter gene amplified by use of a pair of K14 primers inserted together into pUChsneo |
| 07/22/2003 | US6596513 DNA sequence possessing regulated transcriptional promoter activity in two directions; expression vectors; use for the production of recombinant proteins from either homologous or heterologous sources |
| 07/22/2003 | US6596512 Nucleotide sequence coding nematode dopamine transport protein for use as tool in prevention and treatment of parasitic infection; for use in treatment of psychological disorders |
| 07/22/2003 | US6596511 Methods of refolding proteins |
| 07/22/2003 | US6596510 Secretion of carrier-bound proteins into the periplasma and the extracellular space |
| 07/22/2003 | US6596509 Expression vector for use as gene transfer tool in genetic engineering |
| 07/22/2003 | US6596508 Plasmid for use in te expressing of heterologous proteins |
| 07/22/2003 | US6596506 Double and triple readout assay systems |
| 07/22/2003 | US6596498 Bone stimulating factor |
| 07/22/2003 | US6596496 Detecting preferential particle in sample; obtain spore sample, incubate with germination agent, monitor sample for spore generation |
| 07/22/2003 | US6596491 Tenascin-C nucleic acid ligands |
| 07/22/2003 | US6596485 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries |
| 07/22/2003 | US6596484 Detection of differences and similarities in nucleotde sequences; obtain nucleotide sequences, incubate with endonuclease, insert nucleotide sequences, expose to primers, amplify, determine sequences, detect similarities |
| 07/22/2003 | US6596475 Protein conjugates containing multimers of green fluorescent protein |
| 07/22/2003 | US6596473 Detection of antiapotosis protein; obtain genetically engineered cells, measure viable cells, incubate with antiapoptosis agent, compare with control, evaluate adjustment in apoptosis activity |
| 07/22/2003 | US6596281 Mycobacterium tuberculosis specific proteins and genes, mixtures of antigens and uses thereof |
| 07/22/2003 | US6596280 Live bimavirus such as infectious bursal disease virus |
| 07/22/2003 | US6596279 Immunodeficiency recombinant poxvirus |
| 07/22/2003 | CA2329473C Dna encoding prostaglandin receptor ep1 |
| 07/22/2003 | CA2229775C Recombinant conglutinin and producing method thereof |
| 07/22/2003 | CA2220515C Process for producing erythropoietin containing no animal proteins |
| 07/22/2003 | CA2109320C Peptide nucleic acids |
| 07/22/2003 | CA2045891C Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages |
| 07/18/2003 | CA2369985A1 Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach |
| 07/17/2003 | WO2003058253A1 Modular systems and methods for using sample processing devices |
| 07/17/2003 | WO2003058248A2 Diagnostics and vaccines for mycrobacterium paratuberculosis infections |
| 07/17/2003 | WO2003058233A1 Method of screening compound having fungal cell wall synthesis inhibitory activity |
| 07/17/2003 | WO2003058228A1 Electrophoresis-use microchip |
| 07/17/2003 | WO2003058193A2 Microarrays for cell phenotyping and manipulation |
| 07/17/2003 | WO2003058021A2 Novel apoptosis-inducing dna sequences |
| 07/17/2003 | WO2003057926A1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/17/2003 | WO2003057924A1 Proofreading, error deletion, and ligation method for synthesis of high-fidelity polynucleotide sequences |
| 07/17/2003 | WO2003057921A1 Dna immunization with libraries of minigenes encoding degenerate variants of major histocompatibility class i restricted epitopes |
| 07/17/2003 | WO2003057916A2 Cancer profiles |
| 07/17/2003 | WO2003057915A2 Methods of detecting hcv genotype 1 (hcv-1) by using primers specific for the 5’ non-coding region (ncr) of the hcv genome |
| 07/17/2003 | WO2003057914A2 METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS mRNA |
| 07/17/2003 | WO2003057913A2 Method for the detection and/or identification of the original animal species in animal matter contained in a sample |
| 07/17/2003 | WO2003057911A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |
| 07/17/2003 | WO2003057910A2 Use of silica material in an amplification reaction |
| 07/17/2003 | WO2003057906A1 A new vector for genetically modifying non-human animals |
| 07/17/2003 | WO2003057899A2 Ion transporter stress-related polypeptides and methods of use in plants |
| 07/17/2003 | WO2003057898A2 Methods and materials for modulating p2x2 |
| 07/17/2003 | WO2003057897A2 Recombinant protein expression |
| 07/17/2003 | WO2003057892A2 Viruses with enhanced lytic potency |
| 07/17/2003 | WO2003057891A1 Method for preparing transformed cucumis vulgaris |
| 07/17/2003 | WO2003057890A1 Method for preparing transformed cucumis melo |
| 07/17/2003 | WO2003057889A1 Method for preparing transformed cucumis sativus |
| 07/17/2003 | WO2003057888A1 Cell-specific expression/replication vector |
| 07/17/2003 | WO2003057887A1 Novel udp-n-acetyl-d-galactosamine:polypeptide n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 07/17/2003 | WO2003057886A2 Detection of mutations |
| 07/17/2003 | WO2003057885A1 Hiv-1 virus tat-protein mutants |
| 07/17/2003 | WO2003057884A1 Human serum albumin-timp2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-timp2 fusion protein |
| 07/17/2003 | WO2003057883A1 The human hepatoma-derived growth factor 5, its coding sequence, the method of producing it and the uses of it |
| 07/17/2003 | WO2003057882A1 METHOD OF IDENTIFYING PROTEINS CAMs (CONSTITUTIVELY ACTIVE MUTANTS) |
| 07/17/2003 | WO2003057881A1 Method of stabilizing protein |
| 07/17/2003 | WO2003057879A1 Novel udp-n-acetyl-d-galactosamine:polypeptide n-acetylgalactosamine transferase and nucleic acid encoding the same |
| 07/17/2003 | WO2003057878A1 INDUCTION OF THE FORMATION OF INSULIN-PRODUCING CELLS VIA GENE TRANSFER OF PANCREATIC β-CELL-ASSOCIATED TRANSCRIPTIONAL FACTOR |
| 07/17/2003 | WO2003057876A1 Method of screening multiple squamous carcinoma risk group |
| 07/17/2003 | WO2003057874A1 Disease markers for renal diseaes and utilization thereof |
| 07/17/2003 | WO2003057873A1 Plastic plate and plastic plate assembly |
| 07/17/2003 | WO2003057870A1 Human phosphatidic acid phosphatase type 2-like protein |
| 07/17/2003 | WO2003057869A1 Regulation of human sulfatase |
| 07/17/2003 | WO2003057868A1 Novel n-acetylglucosamines transferase and nucleic acids encoding the same |